Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Gozes

Showing results (81-90 of 135) with videos related to

Pageof 14
Sort By:
The Journal of Clinical Investigation|June 15, 1997
Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factorD A Dibbern, G W Glazner, I Gozes, et al.
Journal of Molecular Neuroscience : MN|January 1, 1993
Learning and sexual deficiencies in transgenic mice carrying a chimeric vasoactive intestinal peptide geneI Gozes, J Glowa, D E Brenneman, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 17, 2001
Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndromeC Y Spong, D T Abebe, I Gozes, et al.
The Journal of Clinical Investigation|November 1, 1994
Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouseP Gressens, J M Hill, B Paindaveine, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 1999
Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug designI Gozes, O Perl, E Giladi, et al.
Annals of the New York Academy of Sciences|February 3, 1999
Multiple actions of a hybrid PACAP antagonist: neuronal cell killing and inhibition of sperm motilityI Gozes, O Perl, R Zamostiano, et al.
Journal of Molecular Neuroscience : MN|February 28, 2002
A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cellsA Sharma, J Walters, Y Gozes, et al.
Molecular and Cellular Endocrinology|June 20, 1997
Transcription of the vasoactive intestinal peptide gene in response to glucocorticoids: differential regulation of alternative transcripts is modulated by a labile protein in rat anterior pituitaryL J Chew, Z D Burke, H Morgan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 11, 2000
Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathwayW K Kim, Y Kan, D Ganea, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptidesD E Brenneman, J Hauser, E Neale, et al.
Pageof 14

Showing results (81-90 of 135) with videos related to

Sort By:
Pageof 14
The Journal of Clinical Investigation|June 15, 1997
Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factorD A Dibbern, G W Glazner, I Gozes, et al.
Journal of Molecular Neuroscience : MN|January 1, 1993
Learning and sexual deficiencies in transgenic mice carrying a chimeric vasoactive intestinal peptide geneI Gozes, J Glowa, D E Brenneman, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 17, 2001
Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndromeC Y Spong, D T Abebe, I Gozes, et al.
The Journal of Clinical Investigation|November 1, 1994
Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouseP Gressens, J M Hill, B Paindaveine, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 1999
Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug designI Gozes, O Perl, E Giladi, et al.
Annals of the New York Academy of Sciences|February 3, 1999
Multiple actions of a hybrid PACAP antagonist: neuronal cell killing and inhibition of sperm motilityI Gozes, O Perl, R Zamostiano, et al.
Journal of Molecular Neuroscience : MN|February 28, 2002
A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cellsA Sharma, J Walters, Y Gozes, et al.
Molecular and Cellular Endocrinology|June 20, 1997
Transcription of the vasoactive intestinal peptide gene in response to glucocorticoids: differential regulation of alternative transcripts is modulated by a labile protein in rat anterior pituitaryL J Chew, Z D Burke, H Morgan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 11, 2000
Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathwayW K Kim, Y Kan, D Ganea, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998
Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptidesD E Brenneman, J Hauser, E Neale, et al.
Pageof 14